<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08436583241257</udiDi>
    <basicUdiDi>843658324FIBRILIN7Q</basicUdiDi>
    <tradeName>FIBRILIN vial 5 ml</tradeName>
    <deviceName>FIBRILIN vial 3 ml</deviceName>
    <manufacturerName>LABORATORIOS FARMACÉUTICOS ROVI, S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000014579</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9099</emdnCode>
    <emdnDescription>VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FIBRILIN vial 5 ml</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:32:49.520Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436583241240</udiDi>
    <basicUdiDi>843658324FIBRILIN7Q</basicUdiDi>
    <tradeName>FIBRILIN vial 3 ml</tradeName>
    <deviceName>FIBRILIN vial 3 ml</deviceName>
    <manufacturerName>LABORATORIOS FARMACÉUTICOS ROVI, S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000014579</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9099</emdnCode>
    <emdnDescription>VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FIBRILIN vial 3 ml</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:32:48.331Z</lastUpdated>
  </row>
</eudamedExport>